Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Teladoc (TDOC) to $19 from $25 and keeps an In Line rating on the shares ahead of Q3 earnings from the healthcare tech and distribution group. In the group, the firm’s top picks include CVS Health (CVS), its top large cap pick, Iqvia (IQV) and R1 RCM (RCM), the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TDOC:
- Teladoc Health to Announce Third Quarter 2023 Financial Results
- Teladoc price target lowered to $25 from $30 at TD Cowen
- Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
- Teladoc call volume above normal and directionally bullish
- Cathie Wood’s ARK Investment bought 351.1K shares of Teladoc today